Rapid determination of clofibric acid in human plasma by high-performance liquid chromatographyPAILLET, M; DOUCET, D; MERDJEAN, H et al.Journal of chromatography. 1986, Vol 375, Num 1, pp 179-183, issn 0021-9673Article

Underestimation of albumin content by bromocresol green, induced by drug displacers and uremiaCALVO, R; CAROLOS, R; ERILL, S et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1985, Vol 23, Num 2, pp 76-78, issn 0174-4879Article

Comparative study of clofibric acid and bilirubin glucuronidation in human liver microsomesDRAGACCI, S; HAMAR-HANSEN, C; FOURNEL-GIGLEUX, S et al.Biochemical pharmacology. 1987, Vol 36, Num 22, pp 3923-3927, issn 0006-2952Article

PHARMACOLOGIE DES HYPOLIPEMIANTSALLAIN P; CAILLEUX A; RICHARD H et al.1979; CONCOURS MED.; FRA; DA. 1979; VOL. 101; NO 21; PP. 3559-3576; BIBL. 32 REF.Article

STUDIO DELLE VARIAZIONI DI ALCUNI PARAMETRI BIOCHIMICI IN PAZIENTI IPERDISLIPIDEMICI TRATTATI CON UNA PREPARAZIONE DI DERIVATI NUOVI DELL'AC. P-CLOROFENOSSIISOBUTIRRICO = VARIATIONS DE QUELQUES PARAMETRES BIOCHIMIQUES CHEZ DES PATIENTS SOUFFRANT D'HYPERDYSLIPIDEMIE APRES ADMINISTRATION DE 2 NOUVEAUX DERIVES DE L'ACIDE P-CHLOROPHENOXYBUTYRIQUEBIANCHI PG; SACCABUSI E.1973; GAZZ. MED. ITAL.; ITAL.; DA. 1973; VOL. 132; NO 3; PP. 143-162; ABS. ANGL.; BIBL. 2P.Serial Issue

Effect of bezafibrate and clofibric acid on the spectroscopic properties of the nitric oxide derivative of ferrous human hemoglobinASCENZI, P; COLETTA, M; DESIDERI, A et al.Journal of inorganic biochemistry. 1992, Vol 48, Num 1, pp 47-53, issn 0162-0134Article

PHARMACOKINETICS OF CLOFIBRATE AND CHLOROPHENOXY ISOBUTYRIC ACID. I. CROSS-OVER STUDIES ON HUMAN VOLUNTEERS = PHARMACOCINETIQUE DU CLOFIBRATE ET DE L'ACIDE CHLOROPHENOXY ISOBUTYRIQUE. I. ETUDES CROISEES SUR DES VOLONTAIRES HUMAINSMANNISTO PT; TUOMISTO J; JOUNELA A et al.1975; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1975; VOL. 36; NO 4; PP. 353-365; BIBL. 10REF.Article

EFFECTS OF DRUG BINDING ON THE ESTERASE-LIKE ACTIVITY OF HUMAN SERUM ALBUMIN. III: EVALUATION OF REACTIVITIES OF THE TWO ACTIVE SITES BY USING CLOFIBRIC ACID AS AN INHIBITORKURONO Y; OHTA N; YOTSUYANAGI T et al.1981; CHEM. PHARM. BULL.; ISSN 0009-2363; JPN; DA. 1981; VOL. 29; NO 8; PP. 2345-2350; BIBL. 13 REF.Article

SPERIMENTAZIONE CLINICA DI UN NUOVO FARMACO NELLA RETINOPATIA ARTERIOSCLEROTICA E DIABETICA = EXPERIMENTATION CLINIQUE D'UN NOUVEAU MEDICAMENT DANS LES RETINOPATHIES ARTERIOSCLEROTIQUES ET DIABETIQUES1972; MINERVA OFTALMOL.; ITAL.; DA. 1972; VOL. 14; NO 3; PP. 107-111; ABS. ANGL.; BIBL. 13REF.Serial Issue

DEPISTAGE ET TRAITEMENT DES HYPERLIPIDEMIES A PROPOS D'UN HYPOLIPEMIANT, LE CLOFIBRIDEPARIS HUGUETTE.sd; FRA; DA. S.D.; 84; 68 P.; 30 CM; BIBL. 118 REF.; TH.: MED./REIMS/1978Thesis

CLOFIBRATE AND CLOFIBRIC ACID: COMPARISON OF THE METABOLIC DISPOSITION IN RATS AND DOGS.CAYEN NM; FERDINANDI ES; GRESELIN E et al.1977; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1977; VOL. 200; NO 1; PP. 33-43; BIBL. 26 REF.Article

HYPERLIPIDEMIES ET CINETIQUE DES MEDICAMENTS HYPOLIPEMIANTSORSETTI A.1975; SEM. HOP., THERAPEUT.; FR.; DA. 1975; VOL. 51; NO 7-8; PP. 377-381Article

CONSIDERAZIONI CLINICHE E PATOGENETICHE SU 26 CASI DI PAZIENTI TRATTATI CON L'ESTERE-PIRIDIL-CARBINOLICO DELL'ACIDO CLOFIBRICO IN ASSOCIAZIONE AD EPARINA A BASSI DOSAGGI = CONSIDERATIONS CLINIQUES ET PATHOGENIQUES SUR 26 MALADES TRAITES AVEC L'ESTER PYRIDYL-CARBINOLIQUE DE L'ACIDE CLOFIBRIQUE EN ASSOCIATION AVEC L'HEPARINE A FAIBLES DOSESRENZI G.1974; GAZZ. MED. ITAL.; ITAL.; DA. 1974; VOL. 133; NO 11; PP. 522-526; ABS. ANGL.; BIBL. 18REF.Article

Preoxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liverLALWANI, N. D; ALVARES, K; KUMUDAVALLI REDDY, M et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 15, pp 5242-5246, issn 0027-8424Article

Factors influencing peroxisome proliferation in cultured rat hepatocytesMITCHELL, A. M; BRIDGES, J. W; ELCOMBE, C. R et al.Archives of toxicology. 1984, Vol 55, Num 4, pp 239-246, issn 0340-5761Article

Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes : detection of drug activation by human liver homogenates and by human plateletsBRONFMAN, M; MORALES, M. N; AMIGO, L et al.Biochemical journal (London. 1984). 1992, Vol 284, pp 289-295, issn 0264-6021, 1Article

Pharmacokinetic and metabolic study of itanoxone in the crab Pachygrapsus marmoratus (Decapoda, Brachyura): comparative study with clofibric acidLAUTIER, J; CHANAL, J.-L; DELHON, A et al.Comparative biochemistry and physiology. C. Comparative pharmacology. 1986, Vol 83, Num 1, pp 143-147, issn 0306-4492Article

The analysis of [¹⁴C]clofibric acid glucuronide and [¹⁴]clofibric acid in plasma and urine using high-performance liquid chromatographyMEFFIN, P. J; ZILM, D. M.Journal of chromatography. 1983, Vol 278, Num 1, pp 101-108, issn 0021-9673Article

A simple and specific high performance liquid chromatography method for the assay of a series of novel dermal penetration enhancersMICHNIAK, B. B; SEYDA, K. L.International journal of cosmetic science. 1993, Vol 15, Num 1, pp 7-13, issn 0142-5463Article

Potent antiplatelet effects of cyclic clofibric acid (CPIB) analogs on human plateletsROMSTEDT, K. J; KIM, S. U; WITIAK, D. T et al.Thrombosis research. 1989, Vol 54, Num 4, pp 289-299, issn 0049-3848Article

HPLC-photolysis-electrochemical detection in pharmaceutical analysis: application to the determination of clofibric acid in human plasmaBACHMAN, W. J; STEWART, J. T.Journal of liquid chromatography. 1989, Vol 12, Num 15, pp 2947-2959, issn 0148-3919Article

Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and manCAYEN, M. N.Pharmacology & therapeutics (Oxford). 1985, Vol 29, Num 2, pp 157-204, issn 0163-7258Article

Hepatic microsomal glucuronidation of clofibric acid in the adult and neonate albino ratODUM, J; ORTON, T. C.Biochemical pharmacology. 1983, Vol 32, Num 23, pp 3565-3569, issn 0006-2952Article

THE EFFECTS OF TIADENOL, CHOFIBRATE AND CLOFIBRIDE ON BILE COMPOSITION IN THE RAT.ROZE C; CUCHET P; SOUCHARD M et al.1977; EUROP. J. PHARMACOL.; NETHERL.; DA. 1977; VOL. 43; NO 1; PP. 57-64; BIBL. 1 P.Article

PHARMAKOKINETIK EINER KOMBINATION VON MAGNESIUM-CHLORPHENOXY-ISOBUTYRAT UND DEM HEXANIKOTINSAEUREESTER DES MESO-INOSITS. = PHARMACOCINETIQUE D'UNE ASSOCIATION DE MAGNESIUM CHLORPHENOXYISOBUTYRATE ET DE L'HEXANICOTINATE DE MESOINOSITOLPALTAUF F; PRISTAUTZ H; ABOU EL EISCH I et al.1977; ACTA MED. AUSTR.; AUTR.; DA. 1977; VOL. 4; NO 3; PP. 120-124; ABS. ANGL.; BIBL. 12 REF.Article